Login to Your Account

Amgen Product Sales, Revenues Fall Short of Street Estimates

By Karen Pihl-Carey
Staff Writer

Thursday, April 25, 2013
Amgen Inc.'s first quarter earnings fell short of Wall Street estimates, with the Thousand Oaks, Calif.-based company posting $4.24 billion in revenues, shy of the $4.38 billion expected by consensus.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription